Caspase 2-mediated tumor suppression involves survivin gene silencing
Open Access
- 23 November 2009
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (9) , 1280-1292
- https://doi.org/10.1038/onc.2009.428
Abstract
One of the pivotal functions of endogenous tumor suppression is to oppose aberrant cell survival, but the molecular requirements of this process are not completely understood. Here, we show that caspase 2, a death effector with largely unknown functions, represses transcription of the survivin gene, a general regulator of cell division and cytoprotection in tumors. This pathway involves caspase 2 proteolytic cleavage of the nuclear factor κB (NFκB) activator, RIP1. In turn, loss of RIP1 abolishes transcription of NFκB target genes, including survivin, resulting in deregulated mitotic transitions, enhanced apoptosis and suppression of tumorigenicity in vivo. Therefore, caspase 2 functions as an endogenous inhibitor of NFκB-dependent cell survival and this mechanism may contribute to tumor suppression in humans.Keywords
This publication has 58 references indexed in Scilit:
- Characterization of Cytoplasmic Caspase-2 Activation by Induced ProximityMolecular Cell, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- The enigma of caspase-2: the laymen's viewCell Death & Differentiation, 2008
- Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated TumorigenesisMolecular Cell, 2008
- IAPs: What's in a Name?Molecular Cell, 2008
- Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-κB pathwayThe EMBO Journal, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005
- Intrinsic tumour suppressionNature, 2004
- Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidyOncogene, 2004